Hiatal Hernia Repair Operation In Clearwater, FL

Four tests answer four different questions. Skipping one is the most common route to the wrong operation.

pH monitoring is the standard for proving reflux exists. It runs 48 to 72 hours using either a wireless Bravo capsule or a catheter, while you eat, sleep, work, and exercise normally. It measures how often reflux happens, how long each episode lasts, how acidic it is, when it occurs, and whether your symptoms line up with actual reflux events. A snapshot taken in a clinic cannot capture any of that.

Esophageal manometry measures strength and coordination. Every anti-reflux operation adds resistance at the gastroesophageal junction. If your esophagus cannot push food past that resistance, the result is dysphagia. Manometry is also how achalasia, esophageal spasm, and ineffective motility get caught before an operation makes them worse. The findings determine whether a full wrap is safe, whether a partial wrap is the better choice, and whether a magnetic device is appropriate at all.

Barium swallow is used selectively, mostly when food sticks or anatomy needs another look. One finding from it is worth knowing before you describe your symptoms: where a patient feels food catch matches the actual anatomic location only about 60 percent of the time. Someone certain the problem is in their throat frequently turns out to have delay in the lower esophagus.

Dual-channel pH impedance testing is the one most Clearwater patients have not been offered. Standard reflux testing measures only above the lower esophageal sphincter. Dr. Grandhige uses a customized 24-hour probe that measures above both the lower and the upper esophageal sphincter, and measures non-acid reflux, including bile, pepsin, and trypsin, which only impedance detects. The reason this matters is sensitivity. The esophagus tolerates 40 to 50 reflux episodes a day. The larynx and pharynx can produce symptoms from one.

Patients with throat clearing, hoarseness, cough, or a lump sensation are routinely told surgery has roughly a 50 percent chance of helping them. That number reflects imprecise selection, not the ceiling of the operation. With dual-channel testing identifying who actually has reflux reaching the larynx, expected improvement rises to about 80 percent. Roughly 50 to 60 percent of silent reflux patients test into surgical candidacy. The other 40 to 50 percent are told no, which is the point of running the test. Reimbursement for this study is poor, which is a large part of why most centers do not perform it.

RefluxStop has not received FDA approval, and no surgeon in Florida can implant it today.

Several pages ranking for hiatal hernia surgery in this region describe practices adding RefluxStop in 2026 and becoming the only provider of all four anti-reflux procedures. The regulatory record does not support that yet. Implantica submitted its final response to the FDA on the RefluxStop premarket approval application in May 2026, following six pre-approval inspections covering manufacturing, quality systems, and clinical trial conduct. The device carries a CE mark in Europe and has published five-year follow-up data. It has not cleared FDA premarket approval, and it cannot be implanted commercially in this country until it does.

If a surgeon tells you today that they offer RefluxStop, ask for the FDA approval date. Tampa Bay Reflux Institute will offer it when it is approved and not before.

There is no proven winner between mesh reinforcement and sutures alone, and recurrence is more common than most surgical pages admit.

A randomized trial followed for 13 years found radiologic hiatal hernia recurrence in 38 percent of patients repaired with non-absorbable mesh and 31 percent of patients repaired with crural sutures alone, a difference that was not statistically meaningful. Multiple randomized comparisons of absorbable mesh, non-absorbable mesh, and primary repair have reached the same place, and the Society of American Gastrointestinal and Endoscopic Surgeons reports mixed and low-certainty findings on both recurrence and dysphagia. You can read the 13-year randomized follow-up in JAMA Surgery directly.

Two things follow from that. First, a repair that holds for years and then loosens is a known behavior of this operation, not a surgical failure, which is why Dr. Grandhige frames these as functional repairs with a wear profile rather than permanent fixes. Second, the reinforcement decision belongs to the operating room. It is made on hernia size, tissue quality, and what the hiatus looks like once it is exposed, not on a practice’s standing preference for one material.

Gopal Grandhige, MD, FACS is a board-certified general surgeon who has practiced foregut surgery in Tampa Bay since 2009. He earned a Bachelor of Science in Biology from Johns Hopkins University and his medical degree from the University of Michigan. He completed general surgery residency at Yale-New Haven Hospital, followed by two fellowships there: burn and critical care, and foregut and minimally invasive surgery.

He is a Founding Member of the American Foregut Society, a member of the Society of American Gastrointestinal and Endoscopic Surgeons, and a Fellow of the American College of Surgeons. He founded Tampa Bay Reflux Center in 2009 and Tampa Bay Reflux Institute in 2022.

He holds privileges at St. Joseph’s Main Hospital, St. Joseph’s South Hospital, HCA Brandon Hospital, and HCA South Tampa Hospital, and performs all foregut surgery at HCA South Tampa with a single team. The same physician assistant assists every case, participates in operative decisions, and handles postoperative questions, so you are not routed to a provider who has never seen your anatomy.

Board certification can be verified through the American Board of Surgery physician lookup and licensure through the Florida Department of Health Medical Quality Assurance license search.

Tampa Bay Reflux Institute 1315 South Howard Ave., Suite 101 Tampa, FL 33606 Phone: 813.922.2920 Hours: 9 a.m. to 6 p.m., Monday through Friday